Opportunities to participate in clinical trials: awareness among liver patients

Autor: Liam Mistry, Amrita Kaur Athwal, Maria Round, Emma Burke, Alan Hyde, Carmel Maguire, Graham Bunch, Linda Coughlan, Niamh Quann, Diana Hull, Beverley Hook, Kevin MacCabe, Ian Soady, Carol Rawlings

Publikováno v: Gastrointestinal Nursing. 16:30-35

Introduction: The rising burden of liver disease requires new treatment approaches. Clinical trials are one way forward. However, many patients are unaware that they may be eligible to enter a clinical trial. Methods: A survey was designed to determi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::054fb94113d0a55fe489732f85f10c0d
https://doi.org/10.12968/gasn.2018.16.1.30

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome

Autor: R Cramb, Richard B Paisey, Robert K. Semple, Jonathan Hazlehurst, Shaun Bolton, P N Newsome, Rachel K Crowley, Maria Round, Tarekegn Geberhiwot, Laura Gathercole, Sarah Boocock, Jeremy W. Tomlinson, Rachel M. Brown, Matthew J. Armstrong, Michael W O'Reilly

Publikováno v: Gathercole, L L, Hazlehurst, J M, Armstrong, M J, Crowley, R, Boocock, S, O'Reilly, M W, Round, M, Brown, R, Bolton, S, Cramb, R, Newsome, P N, Semple, R K, Paisey, R, Tomlinson, J W & Geberhiwot, T 2016, ' Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alström syndrome ', Liver International, vol. 36, no. 11, pp. 1704-1712 . https://doi.org/10.1111/liv.13163

Background and Aims: Alström syndrome (AS) is a recessive monogenic syndrome characterized by obesity, extreme insulin resistance and multi-organ fibrosis. Despite phenotypically being high risk of non-alcoholic fatty liver disease (NAFLD), there is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e85b6b9e99dd86bb89abc834d29a07
http://ora.ox.ac.uk/objects/uuid:67860c37-c863-4b59-abfa-cdcc4af2027b